Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?

Bone Marrow Transplant. 2006 Jan;37(2):229. doi: 10.1038/sj.bmt.1705201.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Bilirubin / blood
  • Bone Marrow Transplantation* / adverse effects
  • Bone Marrow Transplantation* / mortality
  • Female
  • Humans
  • Hyperbilirubinemia / blood
  • Hyperbilirubinemia / drug therapy*
  • Hyperbilirubinemia / mortality
  • Liver Diseases / blood
  • Liver Diseases / drug therapy*
  • Liver Diseases / etiology
  • Liver Diseases / mortality
  • Liver Function Tests / methods
  • Male
  • Methylprednisolone / administration & dosage*
  • Middle Aged
  • Retrospective Studies
  • Transplantation, Autologous
  • Transplantation, Homologous

Substances

  • Anti-Inflammatory Agents
  • Bilirubin
  • Methylprednisolone